王晓梅,助理研究员
电话:0512-65872243
电子邮箱:xiaomeiwang@suda.edu.cn
通讯地址:苏州工业园区仁爱路199号, 邮编215123
个人简历:
王晓梅,18新利体育 医学部放射医学与防护学院,助理研究员。于2019年6月获得中国科学院大学上海应用物理研究所博士学位(博士导师:王建强研究员)。其博士期间主要从事面向我国核能可持续发展及核安全重大需求的锕系促排剂研究,针对开发高效低毒的锕系促排剂展开了一系列研究工作,做出了一系列的原创性工作,并获得了丰硕的研究成果。入职18新利体育 后,继续从事开发新型锕系元素促排剂,并延伸开发低毒高效的皮肤核素去污剂,迄今为止已在Nature Commun.、Inorg. Chem.、Bioconjugate Chem.等国际主流期刊上发表学术论文8篇,其中一作/共同一作5篇,专利3项。
研究方向:
1.锕系元素固体化学
2.锕系核素促排
3.核素体外去污
代表性论著:
Xiaomei Wang,‡ Xing. Dai, ‡ Cen. Shi, Jianmei. Wan, Mark. A. Silver, Linjuan. Zhang, Lanhua. Chen, Xuan. Yi, Bizheng. Chen, Duo. Zhang, Kai. Yang, Juan. Diwu*, Jianqiang. Wang, Yujie. Xu, Ruhong. Zhou*, Zhifang. Chai, Shuao. Wang*. “A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo.”Nat. Commun., 2019, 10, 2570.
Cen Shi,# Xiaomei Wang,# Jianmei Wan, Duo Zhang, Xuan Yi, Zhuanling Bai, Kai Yang, Juan Diwu,* Zhifang Chai, Shuao Wang.* 3,2-Hydroxypyridinone-Grafted Chitosan Oligosaccharide Nanoparticles as Efficient Decorporation Agents for Simultaneous Removal of Uranium and Radiation-Induced Reactive Oxygen Species in Vivo. Bioconjugate Chem. 2018, 29, 3896-3905.
Xiaomei Wang,# Guoxun Ji,# Cen Shi, Juan Diwu*, Lanhua Chen, Daxiang Gui, Jianmei Wan, Mark A. Silver, Jianqiang Wang*, Shuao Wang*.Structural and thermodynamic stability of uranyl-deferiprone complexes and the removal efficacy of U(VI) at the cellular level. Dalton Trans. 2018, 47, 8764-8770.
Xiaomei Wang, # Suqiang Wu, # Jingwen Guan, Lanhua Chen, Cen Shi, Jianmei Wan, Yong Liu, Juan Diwu,* Jianqiang Wang,* and Shuao Wang*. 3-Hydroxy-2-Pyrrolidinone as a Potential Bidentate Ligand for in Vivo Che-lation of Uranyl with Low Cytotoxicity and Moderate Decorporation Efficacy: A Solution Thermodynamics, Structural Chemistry, and in Vivo Uranyl Re-moval Survey. Inorg. Chem., 2019, 58, 3349.
5、Xiaomei Wang,# Hangchao Cao, Li Zhang, Ruirui Zhang, Dong Wang*, Zhou Yang*, Wangli He, Hui Cao, Huai Yang*, Graphene Oxide Modified with Mesogenic Groups and Its Effect in Broad‐Band Reflectors. ChemPlusChem, 2015, 80(4), 673-678.
专利
1.一种羟基吡啶酮配体及其应用,发明专利,201710099851.X.
2.MOF纳米粒子在放射性核素促排剂中的应用,发明专利,CN201910674455.4.
3.吡咯烷酮类化合物的应用,发明专利,CN201910028279.9.